Solid freeform fabrication technology

regenHU SA

Incorporated

13.10.2011

Headquarters

Villaz-St-Pierre

Support

regenHU develops a new Solid Freeform Fabrication technology allowing the manufacturing of bioinductive biocompatible bone substitutes offering an optimal alternative to autologous bone substitutes. Combining an innovative scaffold manufacturing technology and bioinductive materials based on bone morphogenetic proteins, this technology offers new opportunities for fast regenerative medicine. Each year more as one a half million skeletal defects caused by any kind of trauma, tumor, birth malformation need bone substitutes. The market potential for an alternative to autologous bone substitutes is estimated to $1.5 billion/year. regenHU customers are world leading companies in the field of trauma, dental and orthopedics surgery.